Cargando…
Effects of risedronate on fracture risk in postmenopausal women with osteopenia
SUMMARY: This posthoc analysis of four trials studied the efficacy of risedronate to reduce fragility fractures in postmenopausal women with osteopenia (i.e., T-scores between −1 and −2.5). Risedronate reduced the fracture risk by 73% ( = 0.023) in this population of women with low femoral neck bone...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2277453/ https://www.ncbi.nlm.nih.gov/pubmed/17968610 http://dx.doi.org/10.1007/s00198-007-0493-y |